Sam Waksal

(redirected from Samuel D. Waksal)
Also found in: Financial, Wikipedia.
Founder of the biopharmaceutical company ImClone who was convicted of insider trading
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
Samuel D. Waksal, Ph.D., chief executive officer of Kadmon Pharmaceuticals, said, "Kadmon is building a new paradigm for bringing pioneering medicines to market more rapidly and cost effectively.
As ImClone Systems has pioneered research in this area, the attainment of this milestone in the BEC2 program is a significant event for the company," stated Samuel D. Waksal, Ph.D., president and CEO of ImClone Systems Incorporated.
patents gives ImClone and Abbott, a strong proprietary position for RCR technology worldwide," stated Samuel D. Waksal, Ph.D., president and CEO of ImClone Systems Incorporated.